ACADIA Pharmaceuticals Inc. vs Vale SA — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.46 (market cap $5.07B), while Vale SA trades at $14.5 (market cap $61.97B). The key difference: Vale SA is far larger — about 12.2× ACADIA Pharmaceuticals Inc.'s market cap, and Vale SA pays a 8.35% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | VALE | |
|---|---|---|
Market Cap | $5.07B | $61.97B |
Sector | Health | Basic Materials |
52-Week High | $29.41 | $17.82 |
52-Week Low | $20.06 | $9.71 |
Enterprise Value | $4.19B | $78.22B |
Dividend Yield | — | 8.35% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →